Saturday, September 27, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Raises Price Target for Bandwidth Expects Significant Upside

Elaine Mendonca by Elaine Mendonca
January 19, 2024
in Breaking News
0
Telecommunications Industry Stock Exchange
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On January 19, 2024, Thomas Blakey, a prominent analyst at Keybanc, expressed his bullish sentiment towards Bandwidth (NASDAQ:BAND) by maintaining an Overweight rating on the stock. In a significant move, Blakey raised the price target from $14 to $16, signaling his optimistic outlook on the company’s future performance. It is important to highlight that the average stock forecast for Bandwidth Inc (BAND) over the next 12 months stands at $21.17, suggesting a remarkable potential upside of 78.31%.

BAND Stock Shows Positive Price Momentum, Trading Near Bottom of 52-Week Range

On January 19, 2024, BAND stock exhibited positive price momentum, trading near the bottom of its 52-week range and above its 200-day simple moving average. The price of BAND shares increased by $0.28 since the previous market close, representing a rise of 2.17%. BAND stock opened at $13.14, which was $0.26 higher than its previous close. These factors suggest that investors were optimistic about the stock’s performance.

BAND Stock Performance on January 19, 2024: Mixed Results with Growth in Revenue and Net Income

BAND Stock Performance on January 19, 2024:

According to data sourced from CNN Money, BAND reported a total revenue of $573.15 million over the past year, representing a significant increase of 16.75% compared to the previous year. BAND’s total revenue for the third quarter of the same year stood at $152.01 million, indicating a 4.21% increase since the previous quarter.

Moving on to the net income figures, BAND reported a net income of $19.57 million over the past year, representing a remarkable increase of 171.52% compared to the previous year. However, the net income for the third quarter of the same year was -$5.13 million, indicating a decrease of 31.88% since the previous quarter.

Lastly, BAND reported an EPS of -$0.48 over the past year, representing a 55.8% increase compared to the previous year. However, the EPS for the third quarter of the same year was -$0.20, indicating a decrease of 31.6% since the previous quarter.

Overall, BAND’s stock performance on January 19, 2024, reflects a mixed bag of results. While the company has witnessed significant growth in total revenue and net income compared to the previous year, the decline in profitability for the third quarter is a cause for concern. Investors and analysts will closely monitor BAND’s future financial reports to gain a better understanding of the company’s trajectory and make informed investment decisions.

Tags: BAND
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Artificial intelligence Markets and money

ServiceNow Stock A Compounded Growth Success Story

Banking Markets and money

MainStreet Bancshares Prepares for Quarterly Earnings Report

Pharmaceutical Stock Market Today

Mixed Analyst Ratings and Price Projections for Ultragenyx Pharmaceutical

Recommended

Quanta Services Stock

Infrastructure Giant Quanta Services Powers Up With Strategic Acquisition

1 week ago
Opendoor Stock

Opendoor Shares Surge on Renewed Fed Rate Cut Expectations

3 weeks ago
Certara Stock

Can Certara’s Market Leadership in Biosimulation Spark a Stock Revival?

2 weeks ago
Biotechnology Market Capitalization

MaxCyte and Wugen Partner to Revolutionize Cancer Treatments

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Blackstone’s Strategic Expansion Across Multiple Fronts Signals Growth Phase

Wabtec Shares Surge on Historic $4.2 Billion Locomotive Deal

Wells Fargo Emerges from Regulatory Shadow as Growth Path Clears

Smurfit WestRock Shares Defy Strong Sales with Post-Merger Plunge

Harley-Davidson Shares Show Signs of a Turnaround

Rocket Lab’s Strategic Gambit: Growth Amidst Executive Share Sale

Trending

Ideaya Biosciences Stock
Analysis

Clinical Trial Success Fuels Optimism for Ideaya Biosciences

by Felix Baarz
September 27, 2025
0

The oncology-focused biotechnology firm Ideaya Biosciences is demonstrating remarkable momentum in the markets. A combination of encouraging...

U.S. Bancorp Stock

Is U.S. Bancorp Poised for a Major Breakout?

September 27, 2025
FedEx Stock

FedEx Shares Surge on Unexpected Quarterly Strength

September 27, 2025
Blackstone Stock

Blackstone’s Strategic Expansion Across Multiple Fronts Signals Growth Phase

September 27, 2025
Wabtec Stock

Wabtec Shares Surge on Historic $4.2 Billion Locomotive Deal

September 27, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Clinical Trial Success Fuels Optimism for Ideaya Biosciences
  • Is U.S. Bancorp Poised for a Major Breakout?
  • FedEx Shares Surge on Unexpected Quarterly Strength

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com